Alyeska Investment Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $60.8M | Sell |
603,702
-131,298
| -18% | -$13.2M | 0.21% | 134 |
|
2025
Q1 | $56.1M | Sell |
735,000
-200,779
| -21% | -$15.3M | 0.22% | 131 |
|
2024
Q4 | $64.6M | Buy |
935,779
+188,377
| +25% | +$13M | 0.24% | 106 |
|
2024
Q3 | $54.6M | Buy |
747,402
+318,598
| +74% | +$23.3M | 0.28% | 133 |
|
2024
Q2 | $28.7M | Buy |
428,804
+228,804
| +114% | +$15.3M | 0.16% | 170 |
|
2024
Q1 | $5.43M | Buy |
+200,000
| New | +$5.43M | 0.03% | 314 |
|
2023
Q3 | – | Sell |
-127,484
| Closed | -$2.69M | – | 529 |
|
2023
Q2 | $2.69M | Sell |
127,484
-72,516
| -36% | -$1.53M | 0.02% | 367 |
|
2023
Q1 | $3.41M | Buy |
200,000
+50,000
| +33% | +$853K | 0.03% | 315 |
|
2022
Q4 | $3M | Buy |
+150,000
| New | +$3M | 0.03% | 295 |
|
2020
Q1 | – | Sell |
-143,765
| Closed | -$3.43M | – | 393 |
|
2019
Q4 | $3.43M | Sell |
143,765
-124,654
| -46% | -$2.98M | 0.05% | 242 |
|
2019
Q3 | $4.74M | Buy |
268,419
+72,634
| +37% | +$1.28M | 0.07% | 226 |
|
2019
Q2 | $5.01M | Buy |
+195,785
| New | +$5.01M | 0.06% | 221 |
|
2018
Q3 | – | Sell |
-386,372
| Closed | -$9.14M | – | 417 |
|
2018
Q2 | $9.14M | Sell |
386,372
-37,645
| -9% | -$890K | 0.08% | 212 |
|
2018
Q1 | $9.55M | Buy |
424,017
+110,480
| +35% | +$2.49M | 0.08% | 218 |
|
2017
Q4 | $9.78M | Buy |
313,537
+18,439
| +6% | +$575K | 0.08% | 201 |
|
2017
Q3 | $9.21M | Buy |
+295,098
| New | +$9.21M | 0.07% | 236 |
|
2017
Q2 | – | Sell |
-89,786
| Closed | -$1.57M | – | 476 |
|
2017
Q1 | $1.57M | Sell |
89,786
-102,234
| -53% | -$1.79M | 0.01% | 397 |
|
2016
Q4 | $2.54M | Buy |
+192,020
| New | +$2.54M | 0.02% | 369 |
|
2015
Q2 | – | Sell |
-115,000
| Closed | -$2.39M | – | 504 |
|
2015
Q1 | $2.39M | Buy |
+115,000
| New | +$2.39M | 0.03% | 330 |
|